Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411943 · ClinicalTrials.gov registry record
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 75
- Enrollment target
NCT01411943 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 75 participants.
The verdict
NCT01411943 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study examines the relationship among epigenetic alterations and the development and persistence of psychoneurologic symptoms (cognitive dysfunction, depressive symptoms, anxiety, fatigue, sleep disturbance, and pain) in women receiving chemotherapy for early stage breast cancer. The relationship among inflammatory markers and psychoneurologic symptoms will also be explored. It is hypothesized: 1. Chemotherapy triggers inflammatory activation, which in turn leads to the acquisition of genetic alterations. These alterations result in cellular changes and are modified over time. 2. Inflammatory activation and epigenetic alterations are related to the temporal development, severity, and persistence of psychoneurologic symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411943
The ClinicalTrials.gov registry entry for NCT01411943 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01411943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411943 about?
NCT01411943 is a clinical study titled "Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer". This study examines the relationship among epigenetic alterations and the development and persistence of psychoneurologic symptoms (cognitive dysfunction, depressive symptoms, anxiety, fatigue, sleep disturbance, and pain) in women receiving chemotherapy for early stage breast cancer. The relationsh...
What is the current status of trial NCT01411943?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2011-01. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT01411943?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.